Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, Dionyssiou-Asteriou A, Michalas S
IVF Unit, 1st Department of Ob/Gyn, Athens University Medical School, Alexandra Maternity Hospital, Greece.
Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):77-80. doi: 10.1016/j.ejogrb.2004.12.021.
To examine whether exogenous LH administration has a beneficial effect on the quality of oocytes, fertilization potential, as well as pregnancy rate in IVF-ET cycles. A randomized trial comparing r-FSH versus r-FSH and LH was employed.
Forty-six infertile couples entering IVF-ET for the first time (either tubal or male factor) were divided after prospective randomization into two groups. In both groups the long protocol with GnRH-analogs was used. In group A, ovarian stimulation started with r-FSH (200 IU/day) for the first four days. In group B, the stimulation protocol started with one amp hMG (75 IU FSH + 75 IU LH activity) daily for four days, with simultaneous administration of r-FSH (150 IU/day). The outcome was compared.
Statistical difference was observed in the number of mature oocytes, the number of fertilized oocytes as well as the number of transferable embryos. In all cases, results were statistically significantly better (p < 0.05) in group B. Clinical pregnancy rate, finally, was similar in the two groups.
The relatively small sample size does not allow a definitive conclusion for the important role of LH during early oocyte maturation. Our results, however, indicate a beneficial effect when small doses of LH are used for ovarian stimulation in IVF-ET cycles. This effect may be more important in cases in which few embryos are available for transfer.
探讨在体外受精 - 胚胎移植(IVF - ET)周期中,外源性促黄体生成素(LH)的使用是否对卵母细胞质量、受精潜能以及妊娠率有有益影响。采用了一项比较重组促卵泡素(r - FSH)与重组促卵泡素加促黄体生成素的随机试验。
46对首次接受IVF - ET的不孕夫妇(输卵管因素或男性因素)经前瞻性随机分组后分为两组。两组均采用促性腺激素释放激素类似物的长方案。A组,在前四天以重组促卵泡素(200国际单位/天)开始卵巢刺激。B组,刺激方案从每天一次注射一支人绝经期促性腺激素(hMG,75国际单位促卵泡素 + 75国际单位促黄体生成素活性)持续四天开始,同时给予重组促卵泡素(150国际单位/天)。对结果进行比较。
在成熟卵母细胞数量、受精卵母细胞数量以及可移植胚胎数量方面观察到统计学差异。在所有情况下,B组的结果在统计学上均显著更好(p < 0.05)。最终,两组的临床妊娠率相似。
相对较小的样本量使得无法就促黄体生成素在早期卵母细胞成熟过程中的重要作用得出明确结论。然而,我们的结果表明,在IVF - ET周期中使用小剂量促黄体生成素进行卵巢刺激具有有益效果。这种效果在可供移植的胚胎数量较少的情况下可能更为重要。